174 related articles for article (PubMed ID: 18626150)
1. Immunoprofile of Hodgkin's lymphoma in India.
Patkar N; Mehta J; Kulkarni B; Pande R; Advani S; Borges A
Indian J Cancer; 2008; 45(2):59-63. PubMed ID: 18626150
[TBL] [Abstract][Full Text] [Related]
2. CD20 positivity in classical Hodgkin's lymphoma: Diagnostic challenge or targeting opportunity.
Barakzai MA; Pervez S
Indian J Pathol Microbiol; 2009; 52(1):6-9. PubMed ID: 19136769
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic significance of CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's Lymphoma].
Fu XH; Wang SS; Huang Y; Xiao J; Zhai LZ; Xia ZJ; Huang HQ; Sun XF; Lin TY
Ai Zheng; 2008 Nov; 27(11):1197-203. PubMed ID: 19000453
[TBL] [Abstract][Full Text] [Related]
4. Peripheral T-cell lymphomas expressing CD30 and CD15.
Barry TS; Jaffe ES; Sorbara L; Raffeld M; Pittaluga S
Am J Surg Pathol; 2003 Dec; 27(12):1513-22. PubMed ID: 14657710
[TBL] [Abstract][Full Text] [Related]
5. Hodgkin lymphoma: A clinicopathological and immunophenotypic study.
Konkay K; Paul TR; Uppin SG; Rao DR
Indian J Med Paediatr Oncol; 2016; 37(1):59-65. PubMed ID: 27051160
[TBL] [Abstract][Full Text] [Related]
6. Classical Hodgkin's disease. Clinical impact of the immunophenotype.
von Wasielewski R; Mengel M; Fischer R; Hansmann ML; Hübner K; Franklin J; Tesch H; Paulus U; Werner M; Diehl V; Georgii A
Am J Pathol; 1997 Oct; 151(4):1123-30. PubMed ID: 9327746
[TBL] [Abstract][Full Text] [Related]
7. Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with CD30-positive lymphocyte-predominant (LP) cells.
Seliem RM; Ferry JA; Hasserjian RP; Harris NL; Zukerberg LR
J Hematop; 2011 Sep; 4(3):175. PubMed ID: 32288859
[TBL] [Abstract][Full Text] [Related]
8. Hodgkin's and non-Hodgkin's lymphoma: spectrum of morphologic and immunophenotypic overlap.
Elgin J; Phillips JG; Reddy VV; Gibbs PO; Listinsky CM
Ann Diagn Pathol; 1999 Oct; 3(5):263-75. PubMed ID: 10556472
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of Hodgkin's disease in Kampala, Uganda.
Tumwine LK
East Afr Med J; 2004 Aug; 81(8):384-7. PubMed ID: 15622930
[TBL] [Abstract][Full Text] [Related]
10. [Expression and significance of B-cell-specific activator protein of H/RS cell in classical Hodgkin's Lymphoma].
Zhou X; Zhao T; Qi Z; Liu G; Zhu M
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1532-5. PubMed ID: 12609061
[TBL] [Abstract][Full Text] [Related]
11. CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center.
Menke JR; Spinner MA; Natkunam Y; Warnke RA; Advani RH; Gratzinger DA
Arch Pathol Lab Med; 2021 Jun; 145(6):753-758. PubMed ID: 32991677
[TBL] [Abstract][Full Text] [Related]
12. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma].
Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Li L; Luo XL
Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292
[TBL] [Abstract][Full Text] [Related]
13. Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma.
Eberle FC; Song JY; Xi L; Raffeld M; Harris NL; Wilson WH; Pittaluga S; Jaffe ES
Am J Surg Pathol; 2012 May; 36(5):716-25. PubMed ID: 22367293
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and differential diagnosis of nodular lymphocyte-predominant Hodgkin's lymphoma.
Liu Y; Zhu X; Zhuang H; Lin H; Wu Q; Jiang G; Gu Y; Luo D; Luo X
Zhonghua Bing Li Xue Za Zhi; 2002 Jun; 31(3):227-30. PubMed ID: 12475440
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis.
Slack GW; Ferry JA; Hasserjian RP; Sohani AR; Longtine JA; Harris NL; Zukerberg LR
Leuk Lymphoma; 2009 Jun; 50(6):937-43. PubMed ID: 19455461
[TBL] [Abstract][Full Text] [Related]
16. Sequential development of Hodgkin's disease and CD30+ diffuse large B-cell lymphoma in a patient with MALT-type lymphoma: evidence of different clonal origin of single microdissected Reed-Sternberg cells.
Parrens M; Vergier B; Fitoussi O; Lahet C; Belleannee G; Marit G; Dubus P; de Mascarel A; Delfau-Larue MH; Merlio JP
Am J Surg Pathol; 2002 Dec; 26(12):1634-42. PubMed ID: 12459631
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotype of Reed-Sternberg and Hodgkin's cells in sequential biopsy specimens of Hodgkin's disease: a paraffin-section immunohistochemical study using the heat-induced epitope retrieval method.
Vasef MA; Alsabeh R; Medeiros LJ; Weiss LM
Am J Clin Pathol; 1997 Jul; 108(1):54-9. PubMed ID: 9208978
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between lymphocyte immunophenotypes and histologic subtypes of Hodgkin's lymphoma and its significance].
Zhang Y; Li XZ; Wen ZH; Chen XY; Zhang G; Wang X; Wu ZQ; Zhao T
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):888-93. PubMed ID: 19698223
[TBL] [Abstract][Full Text] [Related]
19. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of CD15 and CD20 by Reed-Sternberg cells in Hodgkin's disease.
Zukerberg LR; Collins AB; Ferry JA; Harris NL
Am J Pathol; 1991 Sep; 139(3):475-83. PubMed ID: 1716042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
